Sorter
Keyphrases
Denmark
100%
Confidence Interval
88%
Meta-analysis
43%
Randomized Controlled Trial
40%
Hazard Ratio
39%
National Cohort Study
36%
Randomized Clinical Trial
34%
Placebo
33%
Risk Factors
31%
Systematic Meta-analysis
30%
Odds Ratio
28%
Type 2 Diabetes Mellitus (T2DM)
27%
Multiple Sclerosis
26%
High Risk
26%
Rheumatoid Arthritis
26%
Type 1 Diabetes Mellitus (T1DM)
25%
Heart Failure
24%
Copenhagen
23%
Randomized Trial
23%
Atrial Fibrillation
22%
Quality of Life
22%
Migraine
21%
Europe
21%
Tumor
21%
Clinical Outcomes
20%
All-cause Mortality
20%
Magnetic Resonance Imaging
20%
COVID-19
20%
Comorbidity
19%
Overall Survival
19%
Clinical Trials
19%
Myocardial Infarction
18%
Type I Diabetes
18%
Diabetes
17%
Out-of-hospital Cardiac Arrest
17%
Healthy Controls
17%
Breast Cancer
16%
Inflammation
16%
Cardiovascular Disease
16%
Body Mass Index
15%
Headache
15%
Chemotherapy
15%
Positron Emission Tomography
14%
Type 2 Diabetic Patients
14%
Adverse Events
14%
Cystic Fibrosis
14%
Alzheimer's Disease
14%
Health-related Quality of Life
14%
Cardiovascular Risk
14%
Ultrasound
13%
Incidence Rate
13%
Intensive Care Unit
13%
Pseudomonas Aeruginosa (P. aeruginosa)
13%
Prospective Cohort Study
13%
Obesity
12%
Pregnant Women
12%
Randomized Placebo-controlled Trial
12%
ST-elevation Myocardial Infarction (STEMI)
12%
Physical Activity
12%
Older Adults
12%
Population-based Study
12%
Non-associated
12%
Hospitalization
12%
Ovarian Cancer
12%
Clinical Practice
11%
Cancer Patients
11%
Radiotherapy
11%
Healthy Individuals
11%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
11%
Glucagon-like
11%
Spinal Cord Injury
11%
Cardiovascular Mortality
11%
Computed Tomography
11%
Acute Myocardial Infarction
11%
Clinical Analysis
11%
Register Study
10%
AIMS™
10%
Danish Population
10%
During Pregnancy
10%
Cerebral Blood Flow
10%
Dementia
10%
Prognostic Value
10%
Acute Lymphoblastic Leukemia
10%
Survivors
10%
Adult Patients
10%
Genotype
10%
Low Risk
10%
People Living with HIV (PLHIV)
10%
Interleukin-6
10%
Prostate Cancer
10%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
10%
HIV Patients
10%
Blood Pressure
9%
Blood Samples
9%
Chronic Kidney Disease
9%
Gene Expression
9%
Cerebrospinal Fluid
9%
Antiretroviral Therapy
9%
Patients with Heart Failure
9%
Skeletal muscle
9%
Medicine and Dentistry
Cohort Analysis
69%
Disease
69%
Systematic Review
53%
Neoplasm
44%
Malignant Neoplasm
42%
Randomized Controlled Trial
37%
Meta-Analysis
36%
Diagnosis
35%
Magnetic Resonance Imaging
34%
Symptom
34%
Prevalence
33%
Hazard Ratio
32%
Placebo
31%
Quality of Life
30%
Infection
30%
Biological Marker
28%
Breast Cancer
27%
Heart Failure
26%
Human Immunodeficiency Virus
25%
Cardiovascular System
24%
Diabetes
24%
Randomized Clinical Trial
24%
Apoplexy
23%
Clinical Trial
22%
Adverse Event
22%
Pediatrics
21%
Maturity Onset Diabetes of the Young
21%
Odds Ratio
20%
Cardiovascular Disease
19%
Overall Survival
19%
Surgery
18%
Childbirth
18%
Atrial Fibrillation
18%
Observational Study
18%
Injury
18%
COVID-19
17%
Radiation Therapy
17%
Migraine
16%
Rheumatoid Arthritis
16%
Percutaneous Aortic Valve Replacement
16%
Intensive Care Unit
16%
Body Mass Index
15%
Ovarian Cancer
15%
Cross Sectional Study
15%
Positron Emission Tomography
14%
Out of Hospital Cardiac Arrest
14%
Recurrent Disease
14%
Computer Assisted Tomography
13%
Insulin Dependent Diabetes Mellitus
13%
Headache
13%
Population
13%
Myocardial Infarction
13%
Drug Therapy
12%
Bleeding
12%
Diabetes Mellitus
12%
Prostate Cancer
12%
Multiple Sclerosis
12%
Proportional Hazards Model
11%
Clinician
11%
Acute Lymphoblastic Leukemia
11%
All Cause Mortality
11%
Biopsy
11%
Arm
11%
Positron Emission Tomography-Computed Tomography
11%
Prospective Cohort Study
10%
Adolescent
10%
Rehabilitation Engineering
10%
Health Care Cost
10%
Heart Arrest
10%
Hemodynamic
10%
Physical Activity
10%
Blood Pressure
9%
Patient-Reported Outcome
9%
Wart Virus
9%
Prospective Study
9%
Logistic Regression Analysis
9%
Neonatal Infant
9%
Positron Emission Tomography
9%
Resuscitation
9%
Metastatic Carcinoma
9%
Coronary Artery Disease
9%
Exercise
9%
Combination Therapy
8%
Traumatic Brain Injury
8%
Lung Cancer
8%
Cancer
8%
Surgeon
8%
Intensive Care
8%
Skeletal Muscle
8%
Ischemic Heart Disease
8%
In Vitro
8%
Spinal Cord Injury
8%
Chronic Kidney Disease
8%
Patient with Type 2 Diabetes
8%
Retrospective Study
8%
Cohort Effect
8%
Case-Control Study
8%
Cardiovascular Risk
8%
ST Segment Elevation Myocardial Infarction
8%
Retrospective Cohort Study
8%